Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Avidity Biosciences move AOC 1020 to Phase 3 trials by end of 2024?  | Binary | 5 | 6 months ago | ||
Will Avidity Biosciences' stock price increase by 50% from June 12, 2024, by end of 2024? | Binary | 5 | 6 months ago | ||
Will AOC 1020 receive FDA approval for FSHD treatment by June 30, 2025? | Binary | 5 | 6 months ago | ||
What will be the reduction in DUX4 regulated genes in the next AOC 1020 trial update by March 31, 2025? | Categorical | 5 | 6 months ago | ||
Which drug will show higher efficacy in treating FSHD by end of 2024? | Categorical | 3 | 6 months ago | ||
Which company will have a larger market share in FSHD treatments by end of 2024? | Categorical | 3 | 6 months ago |